Skip to content

Directly Observed antiretroviral Therapy for people living with Human Immunodeficiency Virus (HIV) and Acquired ImmunDeficiency Syndrome (AIDS): a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN48682427
Enrollment
Unknown
Registered
2004-03-02
Start date
2004-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS Infections and Infestations

Interventions

Intervention group: Twice-weekly home visits performed by community-peer educators over a two month period. Thereafter, patients were visited once a week for four months. The purpose of the peer educ

Sponsors

Ministry of Health (Brazil)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. HIV-1 infected individuals 2. 18 years old or older 3. Starting antiretroviral therapy in three AIDS clinics in Porto Alegre (Brazil)

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
1. Adherence to highly active antiretroviral therapy (HAART) at the end of the study (6 months) 2. Diseases progression 3. Occurence of AIDS-related disease/opportunistic infections

Secondary

MeasureTime frame
Not provided at time of registration

Countries

Brazil

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026